Oxford BioMedica (OTCMKTS:OXBDF – Get Free Report) shares gapped down prior to trading on Tuesday . The stock had previously closed at $8.70, but opened at $8.02. Oxford BioMedica shares last traded at $8.02, with a volume of 300 shares traded.
Oxford BioMedica Stock Down 7.8%
The firm has a 50 day moving average of $8.11 and a two-hundred day moving average of $6.21. The company has a quick ratio of 1.67, a current ratio of 1.89 and a debt-to-equity ratio of 3.08.
Oxford BioMedica Company Profile
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.
Recommended Stories
- Five stocks we like better than Oxford BioMedica
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Stellantis Makes a High-Stakes Bet on Jeep
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Nuclear Energy Earnings: Which Names Won and Lost in Q3
- Industrial Products Stocks Investing
- Alphabet: Buffett’s Bet on Its Next Phase of Growth
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.
